176 related articles for article (PubMed ID: 21843643)
1. The structure of NS-398 bound to cyclooxygenase-2.
Vecchio AJ; Malkowski MG
J Struct Biol; 2011 Nov; 176(2):254-8. PubMed ID: 21843643
[TBL] [Abstract][Full Text] [Related]
2. The structural basis of endocannabinoid oxygenation by cyclooxygenase-2.
Vecchio AJ; Malkowski MG
J Biol Chem; 2011 Jun; 286(23):20736-45. PubMed ID: 21489986
[TBL] [Abstract][Full Text] [Related]
3. Crystal structure of rofecoxib bound to human cyclooxygenase-2.
Orlando BJ; Malkowski MG
Acta Crystallogr F Struct Biol Commun; 2016 Oct; 72(Pt 10):772-776. PubMed ID: 27710942
[TBL] [Abstract][Full Text] [Related]
4. Differential inhibition of murine prostaglandin synthase-1 and -2 by nonsteroidal anti-inflammatory drugs using exogenous and endogenous sources of arachidonic acid.
Chulada PC; Langenbach R
J Pharmacol Exp Ther; 1997 Feb; 280(2):606-13. PubMed ID: 9023270
[TBL] [Abstract][Full Text] [Related]
5. Comparison of cyclooxygenase-1 crystal structures: cross-talk between monomers comprising cyclooxygenase-1 homodimers.
Sidhu RS; Lee JY; Yuan C; Smith WL
Biochemistry; 2010 Aug; 49(33):7069-79. PubMed ID: 20669977
[TBL] [Abstract][Full Text] [Related]
6. Molecular modelling of the differential interaction between several non-steroidal anti-inflammatory drugs and human prostaglandin endoperoxide H synthase-2 (h-PGHS-2).
Pouplana R; Lozano JJ; Ruiz J
J Mol Graph Model; 2002 Jan; 20(4):329-43. PubMed ID: 11858641
[TBL] [Abstract][Full Text] [Related]
7. Substrate-selective Inhibition of Cyclooxygeanse-2 by Fenamic Acid Derivatives Is Dependent on Peroxide Tone.
Orlando BJ; Malkowski MG
J Biol Chem; 2016 Jul; 291(29):15069-81. PubMed ID: 27226593
[TBL] [Abstract][Full Text] [Related]
8. Inhibitors of cyclooxygenase-2, but not cyclooxygenase-1 provide structural and functional protection against quinolinic acid-induced neurodegeneration.
Salzberg-Brenhouse HC; Chen EY; Emerich DF; Baldwin S; Hogeland K; Ranelli S; Lafreniere D; Perdomo B; Novak L; Kladis T; Fu K; Basile AS; Kordower JH; Bartus RT
J Pharmacol Exp Ther; 2003 Jul; 306(1):218-28. PubMed ID: 12676885
[TBL] [Abstract][Full Text] [Related]
9. Action at a distance: mutations of peripheral residues transform rapid reversible inhibitors to slow, tight binders of cyclooxygenase-2.
Blobaum AL; Xu S; Rowlinson SW; Duggan KC; Banerjee S; Kudalkar SN; Birmingham WR; Ghebreselasie K; Marnett LJ
J Biol Chem; 2015 May; 290(20):12793-803. PubMed ID: 25825493
[TBL] [Abstract][Full Text] [Related]
10. Human cyclooxygenase-2 is a sequence homodimer that functions as a conformational heterodimer.
Dong L; Vecchio AJ; Sharma NP; Jurban BJ; Malkowski MG; Smith WL
J Biol Chem; 2011 May; 286(21):19035-46. PubMed ID: 21467029
[TBL] [Abstract][Full Text] [Related]
11. Molecular modeling, synthesis and screening of some new 4-thiazolidinone derivatives with promising selective COX-2 inhibitory activity.
Unsal-Tan O; Ozadali K; Piskin K; Balkan A
Eur J Med Chem; 2012 Nov; 57():59-64. PubMed ID: 23047224
[TBL] [Abstract][Full Text] [Related]
12. Structural basis of fatty acid substrate binding to cyclooxygenase-2.
Vecchio AJ; Simmons DM; Malkowski MG
J Biol Chem; 2010 Jul; 285(29):22152-63. PubMed ID: 20463020
[TBL] [Abstract][Full Text] [Related]
13. Identification of novel cyclooxygenase-2 selective inhibitors using pharmacophore models.
Palomer A; Cabré F; Pascual J; Campos J; Trujillo MA; Entrena A; Gallo MA; García L; Mauleón D; Espinosa A
J Med Chem; 2002 Mar; 45(7):1402-11. PubMed ID: 11906281
[TBL] [Abstract][Full Text] [Related]
14. The structure of ibuprofen bound to cyclooxygenase-2.
Orlando BJ; Lucido MJ; Malkowski MG
J Struct Biol; 2015 Jan; 189(1):62-6. PubMed ID: 25463020
[TBL] [Abstract][Full Text] [Related]
15. Effect of inhibitor time-dependency on selectivity towards cyclooxygenase isoforms.
Ouellet M; Percival MD
Biochem J; 1995 Feb; 306 ( Pt 1)(Pt 1):247-51. PubMed ID: 7864817
[TBL] [Abstract][Full Text] [Related]
16. Apoptosis induced by NS-398, a selective cyclooxygenase-2 inhibitor, in human colorectal cancer cell lines.
Hara A; Yoshimi N; Niwa M; Ino N; Mori H
Jpn J Cancer Res; 1997 Jun; 88(6):600-4. PubMed ID: 9263538
[TBL] [Abstract][Full Text] [Related]
17. Effects of cyclooxygenase-2 selective and nitric oxide-releasing nonsteroidal antiinflammatory drugs on mucosal ulcerogenic and healing responses of the stomach.
Ukawa H; Yamakuni H; Kato S; Takeuchi K
Dig Dis Sci; 1998 Sep; 43(9):2003-11. PubMed ID: 9753266
[TBL] [Abstract][Full Text] [Related]
18. Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents.
Kurumbail RG; Stevens AM; Gierse JK; McDonald JJ; Stegeman RA; Pak JY; Gildehaus D; Miyashiro JM; Penning TD; Seibert K; Isakson PC; Stallings WC
Nature; 1996 Dec 19-26; 384(6610):644-8. PubMed ID: 8967954
[TBL] [Abstract][Full Text] [Related]
19. Arg-513 and Leu-531 Are Key Residues Governing Time-Dependent Inhibition of Cyclooxygenase-2 by Aspirin and Celebrex.
Dong L; Anderson AJ; Malkowski MG
Biochemistry; 2019 Sep; 58(38):3990-4002. PubMed ID: 31469551
[TBL] [Abstract][Full Text] [Related]
20. Fluorescent indomethacin-dansyl conjugates utilize the membrane-binding domain of cyclooxygenase-2 to block the opening to the active site.
Xu S; Uddin MJ; Banerjee S; Duggan K; Musee J; Kiefer JR; Ghebreselasie K; Rouzer CA; Marnett LJ
J Biol Chem; 2019 May; 294(22):8690-8698. PubMed ID: 31000626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
